In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures

Stuart M. Cain, Barry Bohnet, Jeffrey LeDue, Andrew Yung, Esperanza Garcı́a, John R. Tyson, Sascha R.A. Alles, Huili Han, Arn M. J. M. van den Maagdenberg, Piotr Kozłowski,

Proceedings of the National Academy of Sciences · 2017 · 57 citations · 37 references

DOIFull text

Open access

Concepts

Abstract

Significance Spreading depression is proposed to underlie migraine with aura, a type of debilitating headache for which few pharmacological treatments are available. The pain drug pregabalin has demonstrated initial promising results for the treatment of migraine in the clinic. Utilizing animal models of congenital migraine and live brain imaging, we describe the cortical and subcortical migration of the spreading depression wave. Further, pregabalin is shown to be effective at suppressing spreading depression initiation, wave speed, and subcortical propagation, and also to affect nerve cell signalling directly. Overall, the study supports the therapeutic potential of pregabalin in both noncongenital migraineurs and patients with mild congenital migraine.

References

37